Advertisements
Pharmaceutical Muscle Building Peptides Thymosin Alpha-1 Acetate CAS 62304-98-7
Price: | US$ 1 / Gram |
---|---|
Minimum Order: | 10g |
Payment Terms: | TT, Western Union, moneygram |
Port of Export: | shanghai |
Product Details
Model No.: | Brand Name: | DMK |
---|
Certification: | SGS, ISO9001 |
---|---|
Specification: |
Certification : GMP, SGS , ISO 9001:2008 , KOSHER Place of Origin : China MOQ : Negotiation Price : Negotiation Payment Terms : Western Union, MoneyGram, Bank Transfer, Bitcoin Supply Ability : 100 KG/Month Delivery Time : Within 7 Work Days Packaging Details : Stealth And Discreet Packaging Product Name : Thymosin α1 Acetate Alias : Thymosin Alpha-1 Acetate Specification : 10mg/vial MF : C129H215N33O55 MW : 3108.28000 Shipping Method : EMS, HKEMS, FEDEX, DHL, UPS, Aramex, ETC |
Packaging & Delivery
Packaging: | aluminum foil |
---|---|
Delivery/Lead Time: | 3-7 working days |
Production Capacity: | 5000kg/M |
Product Description
Abstract Thymosin Alpha-1 is a component of Thymosin Fraction 5 responsible for restoring immune function in animals lacking thymus glands. It was the original peptide synthesized from the Thymosin Fraction 5. Unlike β thymosins, which are genetically and chemically unrelated, Thymosin α1 is produced as a 28-amino acid peptide fragment from a longer, 113-amino acid precursor,prothymosin alpha. Research has shown it to enhance cell-mediated immunity in experimental animals and research subjects..
Thymosin Alpha-1 is being researched for the treatment of Hepatitis B and C, and it is also approved for inclusion with vaccines to boost the immune response in the treatment of other diseases.
Exhibiting a variety of immune regulating properties, thymosin-alpha-1 induces differentiation of murine T-cell precursors and human thymocytes and the terminal differentiation of functionally immature cord blood lymphocytes and induces production of IL-2, high affinity IL-2 receptors, and B-cell growth factors by peripheral blood mononuclear cells. T-helper and cytotoxic/suppressor T-cell populations are targets of thymosin activity. Thymosin-alpha-1 has been shown to increase the efficiency of antigen presentation by macrophages and to be an endogenous modulator of alpha-thrombin activity.
Usage
This product is mainly used for the treatment of chronic hepatitis B immune strengthening agent. Thymosin Alpha-1 is being researched for the treatment of Hepatitis B and C, and it is also approved for inclusion with vaccines to boost the immune response in the treatment of other diseases
SUPPLIER PROFILE
|
|||
---|---|---|---|
Company: | Wuhan Demeikai Biotechnology Co., Ltd | ||
City/State | Wuhan, | Country: | China |
Business Type: | Export - Manufacturer / Trading Company | Established: | 2016 |
Member Since: | 2017 | Contact Person | Sam Wang, Miguel Jones, Icemile Cheng |
SUPPLIER PROFILE
City/State/Country -
Wuhan,
China
Business Type -
Export - Manufacturer / Trading Company
Established -
2016
Member Since -
2017
Contact Person -
Sam Wang, Miguel Jones, Icemile Cheng